Ligand profile
CHEMBL179130
Bioactivity hit from ChEMBL on a similar protein.
Bound to: KP13_00143 — Alpha-xylosidase
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL179130- UniProt (similar protein)
Q653V4- pchembl
- 7.100 (~79.4 nM)
- Target protein
- KP13_00143
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 93.0
- −1 ≤ LogP ≤ 5 -2.97
- MW ≤ 500 Da 163.2
- LogP ≤ 5 -2.97
- H-bond donors ≤ 5 5
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 1
- TPSA ≤ 140 Ų 93.0
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
OC[C@@H]1NC[C@@H](O)[C@@H](O)[C@H]1OOC[C@@H]1NC[C@@H](O)[C@@H](O)[C@H]1O
InChI=1S/C6H13NO4/c8-2-3-5(10)6(11)4(9)1-7-3/h3-11H,1-2H2/t3-,4+,5-,6+/m0/s1InChI=1S/C6H13NO4/c8-2-3-5(10)6(11)4(9)1-7-3/h3-11H,1-2H2/t3-,4+,5-,6+/m0/s1
LXBIFEVIBLOUGU-BGPJRJDNSA-NLXBIFEVIBLOUGU-BGPJRJDNSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- ChEMBL
- Activity
- Active
- Curation
- pdb_similarity_tanimoto
- Binding sites
- PF01055
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL179130 →
- UniProt UniProt Q653V4 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL179130”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_00143.
PDB 10
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 1
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).